Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Eli Lilly to buy Centessa Pharma in $6.3 billion deal
06:53am, Tuesday, 31'st Mar 2026
Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in a deal worth about $6.3 billion to advance treatments for sleep-wake disorde
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
06:45am, Tuesday, 31'st Mar 2026
Centessa's OX2R agonist pipeline includes a potential best-in-class therapeutic with significant promise to meaningfully improve outcomes across a range of sleep-wake disorders Acquisition expands Lil
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move
11:41am, Monday, 30'th Mar 2026
Eli Lilly's $2.75B AI drug deal with Insilico spotlights healthcare ETFs as investors seek diversified exposure to the fast-growing AI-driven pharma space.
Lilly Deepens AI Drug Bet With New Insilico Pact
11:00am, Monday, 30'th Mar 2026
Eli Lilly (LLY, Financials) has expanded its artificial intelligence strategy in drug development with a new agreement with Insilico Medicine that could be wort
Eli Lilly Is Diving Deeper Into AI Drug Discovery With Expanded Insilico Partnership
10:01am, Monday, 30'th Mar 2026
Eli Lilly is doubling down on AI drug development with its latest deal.
Eli Lilly teams up with Insilico to accelerate AI-powered drug development
09:38am, Monday, 30'th Mar 2026
Eli Lilly and Co (NYSE:LLY) has entered into a drug discovery collaboration with Insilico Medicine, a clinical-stage biotechnology firm focused on generative artificial intelligence, to advance the de
Eli Lilly Ramps Up AI Ambitions With This $2.8 Billion Deal. The Stock Rises.
09:17am, Monday, 30'th Mar 2026
Lilly will obtain exclusive rights to sell treatments discovered using InSilico's Pharma.AI model.
Eli Lilly Makes $2.75 Billion Bet on AI-Powered Drug Discovery
08:24am, Monday, 30'th Mar 2026
Pharmaceutical titan Eli Lilly wants to bring medications developed with AI to market. To that end, the company has struck a $2.75 billion deal, announced Sunday (March 29), with Hong Kong-based In
Eli Lilly inks $2.75B AI deal with Insilico, bets on China biotech
03:54am, Monday, 30'th Mar 2026
Global pharmaceutical major Eli Lilly has signed a drug discovery agreement with Insilico Medicine that could be worth up to $2.75 billion. The deal underscores the growing role of artificial intellig
Eli Lilly seeks higher NHS drug prices, rebate overhaul to restart UK investment, FT reports
12:49am, Monday, 30'th Mar 2026
Eli Lilly wants the UK to regularly raise NHS drug prices and phase out a multi-billion-pound rebate scheme if it is to resume investment, its international businesses president Patrik Jonsson t
Eli Lilly, InSilico Strike AI Drug Discovery Deal
10:12pm, Sunday, 29'th Mar 2026
Hong Kong-listed InSilico sad the deal could be valued at as much as $2.75 billion.
Eli Lilly extends partnership with Insilico Medicine for AI-powered drug discovery
08:04pm, Sunday, 29'th Mar 2026
Insilico Medicine said on Sunday it is partnering with Eli Lilly in a deal worth up to $2.75 billion, expanding an existing collaboration on AI-powered drug discovery.
Eli Lilly Secures $2.75 Billion Deal With Insilico Medicine To Bring AI-Developed Drugs To Global Market: Report
03:23pm, Sunday, 29'th Mar 2026
Eli Lilly's deal involves an upfront payment of $115 million to Insilico, with additional payments tied to milestones.
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
09:36am, Sunday, 29'th Mar 2026
Hong Kong-listed Insilico Medicine has reached a deal with U.S. pharma giant Eli Lilly for AI-discovered drugs. The two companies have worked together since 2023.
Eli Lilly to sign $2 billion deal for AI drug development with Hong Kong's Insilico Medicine, FT says
07:15am, Sunday, 29'th Mar 2026
Eli Lilly will sign a $2 billion deal with Hong Kong-listed biotech Insilico Medicine , which uses artificial intelligence for drug discovery, the Financial Times reported on Sund
